The abstract is read at the publisher; the summary is JClub's.
Zotatifin inhibits replication of Bundibugyo virus at low nanomolar concentrations by targeting host eIF4A, with pronounced polypurine enrichment in filoviral 5'UTRs.
- Why it matters: Filoviruses rely on host eIF4A helicase activity, but effective host-directed antivirals are needed to counter Ebola and related viruses, including BDBV.
- What they did: The study mapped polypurine enrichment across 5'UTRs of NP, VP35, VP40, GP, VP30, VP24, and L in seven genes from four filovirus species, then tested zotatifin against multiple filoviruses.
- The result: Zotatifin inhibited Ebola, Marburg, Sudan, Tai Forest, and Bundibugyo viruses at low nanomolar concentrations, and PKPD modeling suggests BDBV-inhibitory exposures are achievable in humans at tolerated subcutaneous doses.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.